MoneyWorks4Me

The quarter ended June 2024 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 614.39 millions.Net profit declined -28.75% to Rs. 53.29 millions from Rs. 74.79 millions.Operating profit surged to 116.82 millions from the corresponding previous quarter of 106.34 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 614.39 601.53 2.14 614.39 601.53 2.14 2087.02 2367.14 -11.83
Other Income 14.44 19.97 -27.69 14.44 19.97 -27.69 92.79 57.34 61.82
PBIDT 116.82 106.34 9.86 116.82 106.34 9.86 323.46 398.85 -18.90
Interest 2.15 1.50 43.33 2.15 1.50 43.33 8.14 4.13 97.09
PBDT 81.82 104.84 -21.96 81.82 104.84 -21.96 315.32 360.13 -12.44
Depreciation 10.72 3.93 172.77 10.72 3.93 172.77 16.63 12.05 38.01
PBT 71.10 100.91 -29.54 71.10 100.91 -29.54 298.69 348.08 -14.19
TAX 17.81 26.12 -31.81 17.81 26.12 -31.81 74.06 80.87 -8.42
Deferred Tax 1.94 0.11 1663.64 1.94 0.11 1663.64 -1.54 4.55 -133.85
PAT 53.29 74.79 -28.75 53.29 74.79 -28.75 224.63 267.21 -15.94
Equity 132.29 130.99 0.99 132.29 130.99 0.99 132.19 130.99 0.92
PBIDTM(%) 19.01 17.68 7.56 19.01 17.68 7.56 15.50 16.85 -8.02

Jagsonpal Pharma Share Price

226.80 -2.75 (-1.20%)
14-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1924.90
Dr. Reddys Labs. 1202.00
Cipla 1450.00
Lupin 2235.00
Zydus Lifesciences 1140.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: